These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25044621)

  • 1. Reframing the impact of combined heart-liver allocation on liver transplant wait-list candidates.
    Goldberg DS; Reese PP; Amaral S; Abt PL
    Liver Transpl; 2014 Nov; 20(11):1356-64. PubMed ID: 25044621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in acceptance of organ offers by pediatric transplant centers and its impact on wait-list mortality.
    Mitchell E; Loomes KM; Squires RH; Goldberg D
    Liver Transpl; 2018 Jun; 24(6):803-809. PubMed ID: 29506323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates.
    Husain SA; King KL; Pastan S; Patzer RE; Cohen DJ; Radhakrishnan J; Mohan S
    JAMA Netw Open; 2019 Aug; 2(8):e1910312. PubMed ID: 31469394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
    Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
    Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying Sex-Based Disparities in Liver Allocation.
    Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
    JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of whole-organ in lieu of split-liver transplantation over the last decade: Children experienced increased wait time and death.
    Valentino PL; Emre S; Geliang G; Li L; Deng Y; Mulligan D; Rodriguez-Davalos MI
    Am J Transplant; 2019 Nov; 19(11):3114-3123. PubMed ID: 31152483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
    Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival on the Heart Transplant Waiting List.
    Bakhtiyar SS; Godfrey EL; Ahmed S; Lamba H; Morgan J; Loor G; Civitello A; Cheema FH; Etheridge WB; Goss J; Rana A
    JAMA Cardiol; 2020 Nov; 5(11):1227-1235. PubMed ID: 32785619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States.
    Kwong A; Kim WR; Mannalithara A; Heo NY; Udompap P; Kim D
    Liver Transpl; 2018 Jun; 24(6):735-743. PubMed ID: 29125676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist.
    Choi AY; Mulvihill MS; Lee HJ; Zhao C; Kuchibhatla M; Schroder JN; Patel CB; Granger CB; Hartwig MG
    JAMA Cardiol; 2020 Jun; 5(6):660-668. PubMed ID: 32293647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Wait-List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates.
    Ziogas IA; Hickman LA; Matsuoka LK; Izzy M; Montenovo MI; Rega SA; Feurer ID; Alexopoulos SP
    Liver Transpl; 2020 Sep; 26(9):1112-1120. PubMed ID: 32475062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts.
    Singh TP; Almond CS; Taylor DO; Graham DA
    Circ Heart Fail; 2012 Mar; 5(2):249-58. PubMed ID: 22247484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.